Located in Belvidere, IL, Rosecrance Belvidere offers
outpatient care for people seeking help with substance use and related challenges.
The program offers levels of care including outpatient and typical program lengths around 30+ days.
Treatment draws on evidence-based and supportive therapies such as 1-on-1 counseling,
cognitive behavioral therapy,
group therapy, life skills, online therapy and relapse prevention counseling and a treatment philosophy that is evidence-based, individual treatment and medical, tailored to the individual.
The program serves men, women, adolescents, older adults and young adults and treats co-occurring disorders, drug addiction, prescription drugs, benzodiazepines, heroin and methamphetamine.
Rosecrance Belvidere accepts 24 insurance options, including Anthem, BlueCross BlueShield, Bright Health and CareFirst, and can help verify your specific benefits.
Ongoing support continues after treatment through continuing care, outpatient treatment, support meetings and recovery coach.
For details on admissions, availability, and coverage, reach out to Rosecrance Belvidere or call our 24/7 helpline.
Evidence-Based Context: According to SAMHSA's National Survey on Drug Use and Health (2023), approximately 48.7 million Americans aged 12 or older had a substance use disorder in the past year. The National Institute on Drug Abuse (NIDA) emphasizes that treatment programs combining behavioral therapy with medication-assisted approaches show the highest rates of sustained recovery. Facilities like Rosecrance Belvidere provide structured pathways to evidence-based care.
Sources: SAMHSA NSDUH 2023, NIDA Principles of Drug Addiction Treatment (4th Ed.)